These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

384 related items for PubMed ID: 20510763

  • 1. Innovative use of topical calcineurin inhibitors.
    Lin AN.
    Dermatol Clin; 2010 Jul; 28(3):535-45. PubMed ID: 20510763
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of topical calcineurin inhibitors in vitiligo.
    Wong R, Lin AN.
    Int J Dermatol; 2013 Apr; 52(4):491-6. PubMed ID: 23331250
    [Abstract] [Full Text] [Related]

  • 3. Potential new indications of topical calcineurin inhibitors.
    Luger T, Paul C.
    Dermatology; 2007 Apr; 215 Suppl 1():45-54. PubMed ID: 18174692
    [Abstract] [Full Text] [Related]

  • 4. Topical pimecrolimus for skin disease other than atopic dermatitis.
    Wollina U, Hansel G, Koch A, Abdel-Naser MB.
    Expert Opin Pharmacother; 2006 Oct; 7(14):1967-75. PubMed ID: 17020422
    [Abstract] [Full Text] [Related]

  • 5. Use of pimecrolimus cream in disorders other than atopic dermatitis.
    Day I, Lin AN.
    J Cutan Med Surg; 2008 Oct; 12(1):17-26. PubMed ID: 18258153
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Association between exposure to topical tacrolimus or pimecrolimus and cancers.
    Hui RL, Lide W, Chan J, Schottinger J, Yoshinaga M, Millares M.
    Ann Pharmacother; 2009 Dec; 43(12):1956-63. PubMed ID: 19903860
    [Abstract] [Full Text] [Related]

  • 11. Pimecrolimus cream 1% in erosive oral lichen planus--a prospective randomized double-blind vehicle-controlled study.
    Volz T, Caroli U, Lüdtke H, Bräutigam M, Kohler-Späth H, Röcken M, Biedermann T.
    Br J Dermatol; 2008 Sep; 159(4):936-41. PubMed ID: 18647310
    [Abstract] [Full Text] [Related]

  • 12. An open-label pilot study to evaluate the safety and efficacy of topically applied pimecrolimus cream for the treatment of steroid-induced rosacea-like eruption.
    Chu CY.
    J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):484-90. PubMed ID: 17373975
    [Abstract] [Full Text] [Related]

  • 13. Safety and tolerability of 1% pimecrolimus cream among infants: experience with 1133 patients treated for up to 2 years.
    Paul C, Cork M, Rossi AB, Papp KA, Barbier N, de Prost Y.
    Pediatrics; 2006 Jan; 117(1):e118-28. PubMed ID: 16361223
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pimecrolimus in dermatology: atopic dermatitis and beyond.
    Gisondi P, Ellis CN, Girolomoni G.
    Int J Clin Pract; 2005 Aug; 59(8):969-74. PubMed ID: 16033622
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Efficacy of topical calcineurin inhibitors in lichen planus.
    Samycia M, Lin AN.
    J Cutan Med Surg; 2012 Aug; 16(4):221-9. PubMed ID: 22784514
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics of topical calcineurin inhibitors in adult atopic dermatitis: a randomized, investigator-blind comparison.
    Draelos Z, Nayak A, Pariser D, Shupack JL, Chon K, Abrams B, Paul CF.
    J Am Acad Dermatol; 2005 Oct; 53(4):602-9. PubMed ID: 16198779
    [Abstract] [Full Text] [Related]

  • 20. Pimecrolimus 1% cream for oral erosive lichen planus: a 6-week randomized, double-blind, vehicle-controlled study with a 6-week open-label extension to assess efficacy and safety.
    McCaughey C, Machan M, Bennett R, Zone JJ, Hull CM.
    J Eur Acad Dermatol Venereol; 2011 Sep; 25(9):1061-7. PubMed ID: 21175873
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.